New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2013
07:48 EDTPTXPernix Therapeutics shares could rebound on good execution, says Stifel
After Pernix reported much lower than expected Q1 revenue, Stifel lowered its price target on the stock to $4 from $10 but keeps a Buy rating on the shares based on valuation.
News For PTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 17, 2014
07:41 EDTPTXPernix Therapeutics submits sNDA for TREXIMET use in adolescent patients
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use